ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
18 hedge funds and large institutions have $392K invested in Aridis Pharmaceuticals Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
18
Holding in Top 10
–
Calls
$4K
Puts
–
Top Buyers
| 1 | +$35K | |
| 2 | +$12.3K | |
| 3 | +$4.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.25K |
| 5 |
VF
Virtu Financial
New York
|
+$3K |
Top Sellers
| 1 | -$672K | |
| 2 | -$85.5K | |
| 3 | -$11.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7.25K |
| 5 |
Jane Street
New York
|
-$4.82K |